Senate bill no.1136 (2013) - synthetic drug listing
RELATING TO UNIFORM CONTROLLED SUBSTANCES; AMENDING SECTION 37-2705, IDAHO
CODE, TO REVISE A LISTING OF SYNTHETIC DRUGS; AND DECLARING AN EMER-
Be It Enacted by the Legislature of the State of Idaho:
SECTION 1. That Section 37-2705, Idaho Code, be, and the same is hereby
SCHEDULE I. (a) The controlled substances listed in this sec-
Any of the following opiates, including their isomers, esters,
ethers, salts, and salts of isomers, esters, and ethers, unless specifically
excepted, whenever the existence of these isomers, esters, ethers and salts
is possible within the specific chemical designation:
(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-pip-
Alphacetylmethadol (except levo-alphacetylmethadol also known as
levo-alpha-acetylmethadol, levomethadyl acetate or LAAM);
(8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-pip-
(11) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperid-
(12) Beta-hydroxy-3-methylfentanyl (N-(1-(2-hydroxy-2-phenethyl)-3-
methyl-4-piperidinyl)-N-phenylpropanamide);
(35) 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-pip-
(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
(42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-
(43) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
(53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
Any of the following opium derivatives, their salts, isomers and
salts of isomers, unless specifically excepted, whenever the existence of
these salts, isomers and salts of isomers is possible within the specific
(10) Etorphine (except hydrochloride salt);
preparation which contains any quantity of the following hallucinogenic
substances, their salts, isomers and salts of isomers, unless specifically
excepted, whenever the existence of these salts, isomers, and salts of iso-
mers is possible within the specific chemical designation (for purposes of
this paragraph only, the term "isomer" includes the optical, position and
4-bromo-2,5-dimethoxyphenethylamine (some other names: alpha-
(4) 2,5-dimethoxy-4-ethylamphetamine (another name: DOET);
(5) 2,5-dimethoxy-4-(n)-propylthiophenethylamine;
(7) 5-methoxy-3,4-methylenedioxy-amphetamine;
(9) 4-methyl-2,5-dimethoxy-amphetamine (DOM, STP);
(11) 3,4-methylenedioxymethamphetamine (MDMA);
(12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-et-
hyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, and N-et-
N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hyd-
roxy-alpha-methyl-3,4(methylenedioxy) phenethylamine, and N-hyd-
(15) 5-methoxy-N,N-dimethyltryptamine (also known as 5-methoxy-3-2[2-
(dimethylamino)ethyl]indole and 5-MeO-DMT);
Alpha-ethyltryptamine (some other names: etryptamine, 3-(2-am-
(31) Tetrahydrocannabinols or synthetic equivalents of the substances
contained in the plant, or in the resinous extractives of Cannabis, sp.
and/or synthetic substances, derivatives, and their isomers with simi-
lar chemical structure such as the following:
∆ 1 cis or trans tetrahydrocannabinol, and their opti-
cal isomers, excluding dronabinol in sesame oil and encapsu-
lated in a soft gelatin capsule in a drug product approved by
the U.S. Food and Drug Administration.
b. ∆ 6 cis or trans tetrahydrocannabinol, and their optical
∆ 3,4 cis or trans tetrahydrocannabinol, and its optical
isomers. (Since nomenclature of these substances is not in-
ternationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions are
d. [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2methy-
loctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-
tyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-
dibenzo[b,d]pyran-9-methanol (HU-210) and its geometric
thoyl)indole or 1H-indol-3- yl-(1-naphthyl)methane (1H-in-
(1H-indole-3-yl)(cycloalkyl, cycloalkenyl, aryl)methane,
boxamide by substitution at the nitrogen atoms of the indole
ring or carboxamide to any extent, whether or not further
substituted in or on the indole ring to any extent, whether
or not substituted in the naphthyl ring to any extent in or on
the cycloalkyl, cycloalkenyl, aryl ring(s) (substitution in
the ring may include, but is not limited to, heteroatoms such
thoyl)pyrrole by substitution at the nitrogen atom of the
pyrrole ring to any extent, whether or not further sub-
stituted in the pyrrole ring to any extent, whether or not
substituted in the naphthyl ring to any extent.
c. Any compound structurally derived from 1-(1-naphthyl-
methyl)indene by substitution at the 3-position of the in-
dene ring to any extent, whether or not further substituted
in the indene ring to any extent, whether or not substituted
lacetylindole by substitution at the nitrogen atom of the
indole ring to any extent, whether or not further substi-
tuted in the indole ring to any extent, whether or not sub-
stituted in the phenyl ring to any extent.
e. Any compound structurally derived from 2-(3-hydroxycy-
clohexyl)phenol by substitution at the 5-position of the
phenolic ring to any extent, whether or not substituted in
f. Any compound structurally derived from 3-(benzoyl)in-
dole structure with substitution at the nitrogen atom of
the indole ring to any extent, whether or not further sub-
stituted in the indole ring to any extent and whether or not
substituted in the phenyl ring to any extent.
g. [2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrol-
o[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone
h. 3-dimethylheptyl-11-hydroxyhexahydrocannabinol (HU-
i. [(6S, 6aR, 9R, 10aR)-9-hydroxy-6-methyl-3-[(2R)-
5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahy-
drophenanthridin-1-yl]acetate (CP 50,5561).
(32) Ethylamine analog of phencyclidine:N-ethyl-1-phenylcy-
clohexylamine (1-phenylcyclohexyl) ethylamine; N-(1-phenylcy-
clohexyl) ethylamine, cyclohexamine, PCE;
(33) Pyrrolidine analog of phencyclidine: 1-(phenylcyclohexyl) -
(34) Thiophene analog of phencyclidine 1-[1-(2-thienyl)-cyclohexyl]-
piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP;
(35) 1-[1-(2-thienyl) cyclohexyl] pyrrolidine another name: TCPy;
(36) Spores or mycelium capable of producing mushrooms that contain
(e) Unless specifically excepted or unless listed in another schedule,
any material, compound, mixture or preparation which contains any quantity
of the following substances having a depressant effect on the central ner-
vous system, including its salts, isomers, and salts of isomers whenever the
existence of such salts, isomers, and salts of isomers is possible within the
(1) Gamma hydroxybutyric acid (some other names include GHB; gam-
ma-hydroxybutyrate, 4-hydroxybutyrate; 4-hyroxybutanoic acid; sod-
(2) Flunitrazepam (also known as "R2," "Rohypnol");
Unless specifically excepted or unless listed in an-
other schedule, any material, compound, mixture, or preparation which con-
tains any quantity of the following substances having a stimulant effect on
the central nervous system, including its salts, isomers, and salts of iso-
Aminorex (some other names: aminoxaphen, 2-amino-5-phenyl-2-ox-
azoline, or 4,5-dihydro-5-phenyl-2-oxazolamine);
ha-aminopropiophenone, 2-aminopropiophenone and norephedrone);
pounds listed under a different schedule, structurally derived from
2-aminopropan-1-one by substitution at the 1-position with either
phenyl, naphthyl or thiophene ring systems, whether or not the compound
is further modified in any of the following ways:
By substitution in the ring system to any extent with alkyl,
stituents, whether or not further substituted in the ring system
by one (1) or more other univalent substituents;
By substitution at the 3-position with an acyclic alkyl sub-
iii. By substitution at the 2-amino nitrogen atom with alkyl,
dialkyl, benzyl or methoxybenzyl groups, or by inclusion of the
2-amino nitrogen atom in a cyclic structure.
(5) Methcathinone (some other names: 2-(methyl-amino)-propioph-
enone, alpha-(methylamino)-propiophenone, N-methylcathinone, AL-
(6) (+/-)cis-4-methylaminorex [(+/-)cis-4,5-dihydro-4-methyl-5-
(7) N-benzylpiperazine (also known as: BZP, 1-benzylpiperazine);
(9) N,N-dimethylamphetamine (also known as: N,N-alpha-trimethyl-ben-
An emergency existing therefor, which emergency is hereby
declared to exist, this act shall be in full force and effect on and after its
REGOLAMENTO GENERALE Il Consiglio Accademico Visto il DPR 28/2/2003 n.132 recante “Criteri per l’autonomia statutaria, regolamentare e organizzativa delle Istituzioni artistiche e musicali, a norma della legge 21/12 1999 n.508” Visto lo Statuto dell'Istituto Superiore di Studi Musicali Vittadini, approvato dal MIUR con Decreto n°538 del 13/07/2006 Visto il Decreto del Presidente
MOHAVE COUNTY PLANNING AND ZONING COMMISSION February 9, 2011 REGULAR MEETING MINUTES MEMBERS PRESENT Carl Flusche, Chairman STAFF PRESENT Nicholas S. Hont, P.E. Bob Taylor, Chief Civil Deputy County Attorney Tim Walsh, Public Works Maryann Roche, Environmental Health GUESTS PRESENT David Young Call to Order: Chairman Flusche called the meeting to